Storia in 2 fonti

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mornings like we had on Wednesday are exactly why I get up and do this show eve...

Raccontata da

markets.businessinsider.com

investorplace.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

markets.businessinsider.comStai leggendo1 g fa

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

UniQure's stock jumped 81% after FDA green-lighted AMT-130 gene therapy for Huntington's. Early institutional options positioning before catalysts reveals how binary events move biotech—conviction visible in derivatives weeks before market consensus.

originale

investorplace.com1 g fa

QURE Was Just the Beginning: 5 Biotech Catalysts I'm Watching Now

Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open. UniQure NV (QURE) opened around $43. Touched $48.88 intraday. Closed in the high $47s. Previous close:…

Leggi questa versione → originale

Timeline cronologica

venerdì 19 giugno 2026·markets.businessinsider.com
QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Mornings like we had on Wednesday are exactly why I get up and do this show eve...
venerdì 19 giugno 2026·investorplace.com
QURE Was Just the Beginning: 5 Biotech Catalysts I'm Watching Now
Mornings like we had on Wednesday are exactly why I get up and do this show every single day the market is open. UniQure NV (QURE) opened around $43. Touched $48.88 intraday.…